Whitehawk Therapeutics(DE:3350)
€2.66-0.16 (-5.67%)
DE:3350
Whitehawk Therapeutics earnings date
€2.66
At close:-0.16 (-5.67%)
Whitehawk Therapeutics (3350) Q4 2022 Earnings Report
1 Followers
DE:3350 Q4 2022 EPS Results
- Actual EPS
- -EUR 0.47
- Consensus EPS
- -EUR 0.60
- Beat/Miss
- Beat by +EUR 0.13
- One Year Ago EPS
- -EUR 0.70
DE:3350 Q4 2022 Revenue Results
- Actual Revenue
- EUR 4.72M
- Expected Revenue
- EUR 4.36M
- Beat/Miss
- Beat by +EUR 367.90K
- YoY Revenue Growth
- +422.70%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 03/28/2023
- Time
- Before Open
- Conference Call
- Tuesday, March 28, 2023
DE:3350 Upcoming Earnings
Whitehawk Therapeutics's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
DE:3350 Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3350 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | -0.20- | -0.31 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.19-0.21 | -0.24 | 11.54% (+0.03) | |
| Aug 06, 2026 | 2026 (Q2) | -0.27-0.18 | -0.69 | 73.68% (+0.51) | |
| May 07, 2026 | 2026 (Q1) | -0.32-0.29 | 1.65 | -117.49% (-1.94) | |
| Mar 12, 2026 | 2025 (Q4) | -0.44-0.31 | -0.61 | 49.25% (+0.30) | |
| Nov 06, 2025 | 2025 (Q3) | 0.06-0.24 | -0.42 | 43.48% (+0.18) | |
| Aug 07, 2025 | 2025 (Q2) | 0.75-0.69 | -0.49 | -40.74% (-0.20) | |
| May 08, 2025 | 2025 (Q1) | -0.421.65 | -0.61 | 369.12% (+2.27) | |
| Mar 18, 2025 | 2024 (Q4) | -0.27-0.61 | -0.54 | -11.67% (-0.06) | |
| Nov 06, 2024 | 2024 (Q3) | -0.41-0.42 | -0.54 | 23.33% (+0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
